| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645485 | Annals of Allergy, Asthma & Immunology | 2016 | 6 Pages |
Abstract
Because of the systemic effects on growth and bone health, children should be monitored for growth using stadiometry every 3 to 6 months and BMD should be monitored yearly in patients being treated with high doses of ICSs.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
David P. MD,